Utilization of Anti-obesity Medications After Bariatric Surgery: Analysis of a Large National Database-Reference-Cited by-同舟云学术

Utilization of Anti-obesity Medications After Bariatric Surgery: Analysis of a Large National Database

Published:2024-03-21 Issue:5 Volume:34 Page:1415-1424
ISSN:0960-8923
Container-title:Obesity Surgery
language:en
Short-container-title:OBES SURG

Author:

Firkins Stephen A.,Chittajallu Vibhu,Flora Bailey,Yoo Heesoo,Simons-Linares Roberto^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11695-024-07181-w.pdf

Reference35 articles.

1. World Health Organization. Newsroom. Obesity and overweight. https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight. Accessed 24 Dec 2023

2. Ward ZJ, Bleich SN, Cradock AL, et al. Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381(25):2440–50. https://doi.org/10.1056/NEJMsa1909301.

3. Stierman B, Afful J, Carroll MD, et al. National Health and Nutrition Examination Survey 2017–March 2020 prepandemic data files—development of files and prevalence estimates for selected health outcomes. In: National Health Statistics Reports; no 158. Hyattsville, MD: National Center for Health Statistics; 2021. https://doi.org/10.15620/cdc:106273.

4. Moyer VA, Force USPST. Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(5):373–8. https://doi.org/10.7326/0003-4819-157-5-201209040-00475.

5. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. Oct 13 2004;292(14):1724-1737. https://doi.org/10.1001/jama.292.14.1724

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROS-triggered and macrophage-targeted micelles modulate mitochondria function and polarization in obesity;Nanotechnology;2024-09-06

2. Comment on the Meta-analysis of Liraglutide for Weight Regain: Methodological Considerations;Obesity Surgery;2024-08-10

3. Obesity treatment in adolescents and adults in the era of personalized medicine;Journal of Internal Medicine;2024-07-15

4. Adverse event comparison between glucagon‐like peptide‐1 receptor agonists and other antiobesity medications following bariatric surgery;Diabetes, Obesity and Metabolism;2024-06-27

5. Adverse Event Comparison between Glucagon-like Peptide-1 Receptor Agonists and Other Anti-Obesity Medications Following Bariatric Surgery;2024-04-22